rs281864943
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM4
The NM_000251.3(MSH2):c.4_21dupGCGGTGCAGCCGAAGGAG(p.Ala2_Glu7dup) variant causes a conservative inframe insertion change. The variant allele was found at a frequency of 0.00000416 in 1,442,386 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000251.3 conservative_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000463 AC: 1AN: 215854Hom.: 0 AF XY: 0.00000851 AC XY: 1AN XY: 117460
GnomAD4 exome AF: 0.00000416 AC: 6AN: 1442386Hom.: 0 Cov.: 31 AF XY: 0.00000559 AC XY: 4AN XY: 715818
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:3
- -
This in-frame duplication of 18 nucleotides in MSH2 is denoted c.4_21dup18 at the cDNA level and p.Ala2_Glu7dup (A2_E7dup) at the protein level. The normal sequence, with the bases that are duplicated in brackets, is cATG{dup18}ACGC. The duplicated amino acids are all conserved through species except for the last amino acid, a Glutamic Acid, which is not conserved. This duplication is located in the mismatch binding domain (Lutzen 2008). This variant was reported in an individual with a MSI-High colorectal cancer: however, this tumor was shown to have normal immunohistochemical staining for the Lynch related proteins (Krüger 2003). Since in-frame duplications may or may not inhibit proper protein functioning, the clinical significance of this finding remains unclear at this time and we consider MSH2 Ala2_Glu7dup to be a variant of uncertain significance. -
Variant summary: The MSH2 c.4_21dupGCGGTGCAGCCGAAGGAG (p.Ala2_Glu7dup) variant leads to a duplication of six amino acids (AVQPKE) in exon 1. Mutation taster predicts a benign outcome for this variant. This variant was found in 1/37562 control chromosomes including ExAC at a frequency of 0.0000266, which does not exceed the estimated maximal expected allele frequency of a pathogenic MSH2 variant (0.0005683). This variant has been reported in two patients (one with colon cancer not fulfilling Bethesda criteria and another with Lynch Syndrome patient fulfilling modified Bethesda criteria) without strong evidence for or against pathogenicity (Kruger_2003, Mangold_2005). Tumor from one of the patients showed MSH-I but normal expression of MMR proteins (Kruger_2003). Multiple clinical diagnostic laboratories/reputable databases classified this variant as uncertain significance. Therefore, until additional information becomes available (ie, clinical and functional studies), the variant of interest has been classified as a "Variant of Uncertain Significance (VUS)." -
Hereditary cancer-predisposing syndrome Uncertain:2
This variant causes a duplication of 6 amino acids within the mismatch binding domain of the MSH2 protein. To our knowledge, functional studies have not been performed for this variant. This variant has been reported in an individual affected with colorectal cancer, with the tumor showing high microsatellite instability and normal MLH1/MSH2 expression (PMID: 12655562). This variant has also been reported in an individual suspected of having Lynch syndrome (PMID 15849733). This variant has been identified in 1/215854 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
The c.4_21dup18 variant, located in coding exon 1 of the MSH2 gene, results from an in-frame duplication of 18 nucleotides between positions 4 to 21, causing the duplication of 6 amino acids. This duplication has been detected in an individual with early-onset colorectal cancer, whose tumor was MSI-H, but showed intact MSH2 and MSH6 staining on IHC (Krüger S, Hum. Mutat. 2003 Apr; 21(4):445-6). This region is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This variant, c.4_21dup, results in the insertion of 6 amino acid(s) of the MSH2 protein (p.Ala2_Glu7dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs752412603, gnomAD 0.001%). This variant has been observed in individual(s) with Lynch syndrome (PMID: 15849733). ClinVar contains an entry for this variant (Variation ID: 91114). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at